MicroRNA Expression and Genome-Wide Epigenetic Analysis of Paediatric Acute Lymphoblastic Leukaemia (ALL)

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Acute Lymphoblastic Leukaemia (ALL) is one form of childhood leukaemia, the causes for which are unknown. Evidence suggests genome changes are associated with ALL, specifically epigenetic changes such as DNA methylation and microRNA dysregulation. We aim to investigate these changes associated with childhood ALL. We believe this will refine the current diagnostic measures, more accurately predict patients� treatment response, and detect the minimal residual disease during and after treatment.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2013

Funding Scheme: NHMRC Postgraduate Scholarships

Funding Amount: $71,765.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Epigenetics (incl. Genome Methylation and Epigenomics)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

DNA methylation | acquired cancer | acute leukaemia | biological markers | control of gene expression | diagnosis | leukaemia | microrna | paediatric